1-8 of 8
Sean H. Lim
Close
Sort by
Journal Articles

Clinical and Biological Effects of Combined CD27 and CD20 Antibody Therapy in Relapsed/Refractory B-Cell Lymphoma: The Riva Trial

Sean H Lim, Heng Sheng Sow, Christopher Wignall, Katy Mercer, Josh Caddy, Cherish Boxall, Kerensa Thorne, Joshua Northey, Louise Stanton, Zoë Konn, Keira Fines, Patrick G. Medd, Adam Coleman, Lorna Nunn, Robert Lown, Pamela McKay, Wendy Osborne, Kim Linton, Graham P. Collins, Andrew J Gentles, Matthew Rose-Zerilli, Gareth Griffiths
Journal: Blood
Blood (2021) 138 (Supplement 1): 715.
https://doi.org/10.1182/blood-2021-148332
Published: 2021
Journal Articles

Establishment of an In Vivo Mouse Model to Study and Overcome Infusion Related Reactions Associated with Fcgriib Antibody Administration

Ingrid Karlsson, PhD, Linda Mårtensson, PhD, Marie Borggren, PhD, Mathilda Kovacek, Carl Roos, Therese Blidberg, Robert Oldham, PhD, Mats Jerkeman, MD PhD, Martin J.S. Dyer, MD PhD, Andrew Davies, MD PhD, Raul Córdoba, MD PhD, Pau Abrisqueta, MD PhD, Stephen Beers, PhD, Ingrid Teige, PhD, Andres McAllister, MD PhD, Sean H Lim, MD PhD, Mark S Cragg, PhD, Björn Frendéus, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-138658
Published: 2020
Journal Articles

Optimizing therapy in advanced-stage Hodgkin lymphoma

Clinical Trials & Observations
Sean H. Lim, Peter W. M. Johnson
Journal: Blood
Blood (2018) 131 (15): 1679–1688.
https://doi.org/10.1182/blood-2017-09-772640
Published: 2018
Journal Articles

Anti-CD27 Enhances Lymphoma Immunotherapy through Profound Myeloid Cell Recruitment

Anna H Turaj, MSc, Vikki L Field, Claude H.T. Chan, PhD, Christine A. Penfold, BSc, Jinny H. Kim, PhD, Sonya James, PhD, Kerry L Cox, Tibor Keler, PhD, Peter M Johnson, MA, MD, Aymen Al-Shamkhani, PhD, Stephen A Beers, PhD, Martin J. Glennie, PhD, Mark S Cragg, PhD, Sean H Lim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3024.
https://doi.org/10.1182/blood.V128.22.3024.3024
Published: 2016
Journal Articles

Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity

Andrew T. Vaughan, Chisako Iriyama, Stephen A. Beers, Claude H. T. Chan, Sean H. Lim, Emily L. Williams, Vallari Shah, Ali Roghanian, Bjorn Frendéus, Martin J. Glennie, Mark S. Cragg
Journal: Blood
Blood (2014) 123 (5): 669–677.
https://doi.org/10.1182/blood-2013-04-490821
Published: 2014
Includes: Supplemental data
Journal Articles

Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy

Sean H. Lim, Andrew T. Vaughan, Margaret Ashton-Key, Emily L. Williams, Sandra V. Dixon, H. T. Claude Chan, Stephen A. Beers, Ruth R. French, Kerry L. Cox, Andrew J. Davies, Kathleen N. Potter, C. Ian Mockridge, David G. Oscier, Peter W. M. Johnson, Mark S. Cragg, Martin J. Glennie
Journal: Blood
Blood (2011) 118 (9): 2530–2540.
https://doi.org/10.1182/blood-2011-01-330357
Published: 2011
Includes: Supplemental data
Journal Articles

Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

Waleed Alduaij, Andrei Ivanov, Jamie Honeychurch, Eleanor J. Cheadle, Sandeep Potluri, Sean H. Lim, Kazuyuki Shimada, Claude H. T. Chan, Alison Tutt, Stephen A. Beers, Martin J. Glennie, Mark S. Cragg, Tim M. Illidge
Journal: Blood
Blood (2011) 117 (17): 4519–4529.
https://doi.org/10.1182/blood-2010-07-296913
Published: 2011
Includes: Multimedia, Supplemental data
Journal Articles

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

Stephen A. Beers, Ruth R. French, H. T. Claude Chan, Sean H. Lim, Timothy C. Jarrett, Regina Mora Vidal, Sahan S. Wijayaweera, Sandra V. Dixon, Hyungjin Kim, Kerry L. Cox, Jonathan P. Kerr, David A. Johnston, Peter W. M. Johnson, J. Sjef Verbeek, Martin J. Glennie, Mark S. Cragg
Journal: Blood
Blood (2010) 115 (25): 5191–5201.
https://doi.org/10.1182/blood-2010-01-263533
Published: 2010
Includes: Supplemental data